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Abstract: The separation and chromatographic behaviour of five ACE (angio-
tensin converting enzyme) inhibitors and their four active metabolites were 
investigated by normal-phase thin-layer chromatography on silica using several 
mono- and binary non-aqueous solvent systems. The linear relationship be-
tween the RM values and the composition of employed mobile phase was ob-
tained. The hydrophobicity parameters 0ΜR  and C0 were determined from the 
regression data of the plots, analogous to reversed-phase chromatography. The 
chromatographically obtained hydrophobicity parameters were correlated with 
the calculated log P values. The current results were correlated with the lipo-
philicity of the studied ACE inhibitors and their metabolites, previously esti-
mated by reversed-phase chromatography. 
Keywords: ACE inhibitors; normal-phase thin-layer chromatography; hydro-
phobicity. 
INTRODUCTION 
Due to the utmost significance of structure/biological activity relationships 
of pharmaceuticals, interest in this field of research has been continually in-
creasing. The biological activity of a substance depends on the structural, physic-
cal and chemical properties of its molecule and the lipophilicity (hydrophobi-
city), determining to a great extent biological activity, represents a very impor-
tant feature. Thus, the well-known Lipinski “rule of 5” predicts that poor absorp-
tion or permeation of drugs is more likely when there are more than 5 hydrogen- 
-bond donors or 10 hydrogen-bond acceptors, the molecular weight is greater 
than 500 and the calculated log P (C log P) is greater than 5.1 
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As early as 1964, Fujita et al.2 introduced the concept of hydrophobicity and 
expressed it by the partition (distribution) coefficient as the log P value, defining 
it as the logarithm of the ratio of the concentrations of the examined substance in 
both phases of a saturated biphasic system consisting of 1-octanol and water: 
 log P = log 
w
o
c
c
 (1) 
where co represents the concentration of the substance in 1-octanol and cw its 
concentration in water when the system is at equilibrium. 
The so-called “shake flask” method represents a traditional approach for the 
determination of the lipophilicity of a molecule, i.e., of the log P value.3 How-
ever, since this method suffers from several drawbacks, such as poor reprodu-
cibility, time consuming, impossibility to be applied for extremely hydrophilic or 
lipophilic components, the lipophilicity of a biologically active substances is ex-
perimentally determined at present by chromatographic methods, primarily by 
the highly efficient reversed-phase liquid chromatography (RP-HPLC) and rever-
sed-phase thin-layer chromatography (RP-TLC).3–6 The chromatographic deter-
mination of lipophilicity is based on the distribution of the analyte between an 
expressively non-polar stationary phase (usually RP-18 silica gel) and a polar 
mobile phase (a binary system water – organic solvent with a relatively high 
water content). Taking into consideration that under the conditions of normal- 
-phase chromatography, the analyte is distributed during the chromatographic 
procedure between the two phases significantly differing from each other in po-
larity, it is to be expected that this chromatographic method might be employed 
for the determination of relative lipophilicity. There are even several reports in 
the available literature describing such attempts.7–9 
The chromatographic behaviour of different organic and inorganic, primarily 
biologically active substances, under conditions of reversed- and normal-phase 
planar chromatography has been the subject of our long-range project. Within the 
scope of these studies, the chromatographic behaviour of a series of ACE inhi-
bitors has been examined by the methods of RP-TLC, applying conventional re-
versed-phase chromatography on a thin layer of RP-18 silica gel and binary 
systems water–organic solvent, as well as the salting-out TLC method.10,11 
Based on the obtained results, the parameters of lipophilicity of the examined 
compounds were calculated and correlated to computer-calculated log P values. 
ACE inhibitors belong to a large and very significant family of pharmaceu-
ticals. They are widely applied in clinical practice for the prevention and therapy 
of hypertension, heart failure and myocardial infarction. These drugs occur in 
pharmaceutical formulations as esters, which are enzymatically hydrolyzed under 
in vivo conditions to their di-acid forms representing their active metabolites. 
Lisinopril, already occurring in pharmaceutical formulation in its di-acid form 
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and captopril, which is not subjected to hydrolysis under in vivo conditions but 
forms disulfides, represent two exceptions among the examined ACE inhibi-
tors.12,13 
Among the approaches applied for the determination of ACE inhibitors and 
their metabolites in biological materials and pharmaceutical formulations, several 
methods, such as HPLC,14,15 planar chromatography,15 capillary zone electro-
phoresis,16 spectrophotometry,17 spectrofluorometry17 and gas chromategra-
phy18 have been employed so far. In addition, the activity and activity/physico- 
-chemical properties relationships of these substances, mainly their lipophili-
city,19–21 were most frequently studied by reversed-phase liquid chromatography 
procedures. 
As a continuation of studies on the chromatographic behaviour of ACE inhi-
bitors, this work was concentrated on the examination of the retention of five 
ACE inhibitors and their metabolites employing the method of normal-phase 
thin-layer chromatography (NP-TLC) on silica gel plates. The main objective of 
this study was to investigate the feasibility of applying the NP-TLC method for 
the experimental determination of lipophilicity of these compounds. 
EXPERIMENTAL 
The substances investigated throughout the present study are listed in Table I. 
The TLC experiments were performed on silica gel 10×10 cm TLC plates (Art. 5644, 
Merck, Darmstadt, Germany). The plates were spotted with 2 μl aliquots of freshly prepared 
ethanolic solutions of substances 1, 3, 5 and 8, an aqueous solution of 7 and methanolic so-
lutions of substances 2, 4, 6 and 9 (all about 2 mg/ml) and developed by the ascending 
technique. The solvent systems employed are listed in Tables II and III. All the components 
contained in the employed mobile phases were of analytical grade purity. 
After development, detection was realised by exposing the plates to iodine vapour. All 
investigations were performed in triplicate at ambient temperature (222 °C). 
TABLE I. The investigated substances 
No Structure Name 
1 Enalapril, (S)-1-[N-[1-(ethoxycarbonyl)-3- 
-phenylpropyl]-L-alanyl]-L-proline 
Krka Research and Development Division 
2 Enalaprilat, (S)-1-[N-(1-carboxy-3-phenylpropyl)- 
-L-alanyl]-L-proline dehydrate 
Krka Research and Development Division 
3 Quinapril, [3S-[2[R*(R*)],3R*]]-2-[2-[[1-(etho-
xycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]-
1,2,3,4 -tetrahydro-3-isoquinolinecarboxylic acid 
Parke-Davis Pharmaceutical Research 
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TABLE I. Continued 
No Structure Name 
4 Quinaprilat, [3S-[2[R*(R*)],3R*]]-2-[2-[(1-car- 
boxy-3-phenylpropyl)- amino]-1-oxopropyl]- 
-1,2,3,4-tetra- hydro-3-isoquinoli- 
necarboxylic acid 
Parke-Davis Pharmaceutical Research 
5 Fosinopril, [1 [S*(R*)],2,4]-4-cyclohexyl-1-[[[2- 
-methyl-1-(1-oxo- propoxy)propoxy](4-phenyl-
butyl)-phosphinyl]acetyl]-L-proline 
Bristol-Myers Squibb Pharmaceutical 
Research Institute 
6 Fosinoprilat, trans-4-cyclo-hexyl-1-[[hydroxy(4- 
-phenyl-butyl)phosphinyl]acetyl]-L- proline 
Bristol-Myers Squibb Pharmaceutical 
Research Institute 
7 Lisinopril, (S)-1-[N2-(1-carboxy-3-phenylpropyl)- 
-L-lysyl]-L-proline dehydrate 
Belupo Pharmaceutical & Cosmetic 
Quality Control Department 
8 Cilazapril, [1S-[1,9 (R*)]]-9-[[1-(ethoxy-
carbonyl)-3-phenylpropyl]amino]octahydro- 
-10-oxo-6H-pyridazino[1,2-a]- [1,2]diazepine- 
-1-carboxylic acid monohydrate 
Roche Pharmaceuticals 
9 Cilazaprilat, [1S-[1,9 (R*)]]-9-[(1-carboxy-3- 
-phenylpropyl)amino]octahydro-10-oxo-6H- 
-pyridazino [1,2-a]- [1,2]diazepine- 
-1-carboxylic acid 
Roche Pharmaceuticals 
TABLE II. RF×100 values of the investigated substances obtained by mono-component mo-
bile phase 
Substancea Mobile phase 
1 2 3 4 5 6 7 8 9 
Methanol 81 54 92 86 94 86 12 64 35 
Ethanol 77 22 88 71 92 80 11 44 37 
n-Propanol 67 15 63 38 68 42 10 24 4 
Isoropanol 60 8 63 22 75 55 0 20 0 
Isobutanol 20 2 41 18 43 29 0 16 0 
Acetone 18 0 25 12 14 4 0 8 0 
Ethyl methyl ketone 30 0 41 17 19 14 0 11 0 
aThe numbers denote the substances, see Table I 
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TABLE III. RF×100 values of the investigated substances obtained with two-component mo-
bile phases 
y(ethanol) / % 
Ethanol–ethyl 
methyl ketone 
Ethanol–carbon 
tetrachloride Ethanol–toluene 
Substancea 
50 40 30 20 10 80 70 60 50 40 80 70 60 50 40 
1 59 51 44 34 25 66 59 51 43 35 48 45 42 38 33 
2 6 5 4 3 1 19 16 13 10 5 19 15 12 9 5 
3 77 73 70 68 66 74 69 66 63 60 79 74 68 64 62 
4 67 64 61 57 53 53 47 42 37 29 64 60 57 54 51 
5 62 57 53 49 44 70 62 54 47 40 72 68 65 62 58 
6 14 11 9 6 4 21 18 16 13 9 37 32 25 18 12 
7 5 3 1 0 0 5 3 2 0 0 11 8 6 4 0 
8 37 32 28 22 18 50 46 40 34 28 51 48 46 44 41 
9 7 5 2 0 0 8 6 4 3 0 16 13 10 7 4 
aThe numbers denote the substances, see Table I 
The RM values were calculated for each solute in each mobile phase according to the 
Bate-Smith and Westall equation:22 
 RM = log (1/RF – 1) (2) 
RESULTS AND DISCUSSION 
The chromatographic behaviour of the examined ACE inhibitors and their 
metabolites and the feasibility of applying the normal-phase TLC method for the 
determination of their lipophilicity were investigated using thin-layer silica gel 
plates and several non-aqueous mono- and two-component solvents as the mobile 
phase. The results are summarized in Tables II and III, respectively. 
The results obtained throughout the study of ACE inhibitors and their meta-
bolites employing mono-component solvents (Table II) show a satisfactory ac-
cordance to their chromatographic behaviour with the method of normal-phase 
thin-layer chromatography. Namely, the retention order of the examined sub-
stances obtained by alcohols as the mobile phase is in agreement with the elution 
strength, ε0, as well as with the polarity of the applied solvents, i.e., the less polar 
the solvent, the stronger the retention. Hence, the strongest retention of the 
examined substances was recorded when isobutanol, as the least polar among the 
applied alcohols with a P’ value of 3.9, was used and the weakest retention of the 
ACE inhibitors and their metabolites was observed when the very polar methanol 
(P’ of 6.6)23 was employed. However, such a regularity was not observed in case 
of ketones. 
Also, the results obtained during the examinations of the ACE inhibitors and 
their metabolites applying two-component solvents (Table III) demonstrate a de-
crease of RF values, i.e., increased retention of the examined substances in paral-
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lel with increasing concentrations of the less polar component in the mobile 
phase, which is in accordance with the normal-phase chromatographic mode. 
The results summarized in Tables II and III indicate significant differences 
in the RF values, i.e., in the retention of the examined ACE inhibitors and their 
metabolites. In all instances, it was established that the metabolites exhibit a 
stronger retention, i.e., they have lower RF values compared to the corresponding 
parent ACE inhibitor. Such a behaviour of the examined substances under con-
ditions of normal-phase TLC is contrary to that observed by reversed-phase chro-
matography (both the salting-out method and classical reversed-phase TLC chro-
matography on RP-18 silica) when the retention of the less polar ACE inhibitors 
was found to be much stronger than that of their metabolites. 
This distinction in the chromatographic behaviour of the ACE inhibitors and 
their metabolites results from differences in their interaction with silica gel. 
Namely, due to the presence of two carboxylic groups in the molecule of the 
metabolites (including substance 7), their specific interactions with silica gel 
(hydrogen bonds) are much stronger than those of the corresponding ACE inhi-
bitors, containing only one carboxylic group within their molecule. 
Based on the obtained retention parameters of the examined ACE inhibitors 
and the corresponding metabolites, separation factors (log α) were calculated 
(Table IV). Comparison of these values and the values of the separation factors 
calculated for two reversed-phase systems11 revealed no significant differences 
in the separation selectivity of the ACE inhibitors and their metabolites between 
normal- and reversed-phase methods. 
The retention behaviour of the examined substances obtained by reversed- 
-phase TLC can be graphically presented as the relationship of the RM value and 
the content of the less polar component of the mobile phase. The obtained linear 
relationships can be presented by the equation of a straight line RM = 0ΜR  + mC. 
The value of the intercept, 0ΜR , represents the lipophilicity of the examined 
substance, while the value of the slope, m, corresponds to the specific hydropho-
bic surface area of this substance and C represent the content of the more polar 
component in the mobile phase. Based on the obtained intercept and slope values, 
another hydrophobic parameter, C0 = – 0ΜR /m, can be calculated. This hydropho-
bicity parameter corresponds to the parameter 0, previously defined for the 
HPLC method as the concentration of the organic component in the mobile phase 
for which the distribution of the analyzed substance between the mobile and 
stationary phase is equal (1:1).25 
The same approach was applied in previous attempts to employ normal- 
-phase chromatography for lipophilicity determinations.7–9 Accordingly, the re-
sults obtained throughout the present study by normal-phase TLC are expressed 
analogously to those obtained by reversed-phase chromatography as the relation-
ship of the RM values and the content of ethanol, as the more polar component, in 
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the mobile phase. As seen from Fig. 1, linear relationships with very high values 
of the correlation coefficients were recorded for all employed solvent systems. 
Based on the intercept values and the slope of the plots, the parameter C0 was 
calculated. The obtained regression parameters are presented in Table V. The re-
sults clearly demonstrate lower 0ΜR  values for the more lipophilic compounds, 
i.e. the ACE inhibitors in relation to the corresponding metabolites. This pheno-
menon was the consequence of the application of normal-phase chromatographic 
method for the estimation of hydrophobicity of the examined substances and can 
be solved by presenting linear relationships of the retention and the content of 
less polar (instead of more polar) component in a binary non-aqueous mobile phase. 
TABLE IV. The logarithm of separation factors calculated by relation: log  = |ΔRM|24 
Solvent system ya / % Log 1,2 Log 3,4 Log 5,6 Log 8,9 
50a 1.353 0.217 1.001 0.892 
40 1.296 0.182 1.030 0.951 
30 1.174 0.174 1.057 1.280 
20 1.222 0.205 1.178 – 
Ethanol–ethyl methyl ketone 
10 1.519 0.236 1.275 – 
80 0.918 0.402 0.943 1.061 
70 0.878 0.400 0.871 1.125 
60 0.843 0.428 0.790 1.204 
50 0.832 0.462 0.773 1.222 
Ethanol–carbon tertachloride 
40 1.010 0.565 0.829 – 
80 0.595 0.326 0.641 0.738 
70 0.666 0.278 0.655 0.791 
60 0.725 0.205 0.746 0.885 
50 0.792 0.180 0.871 1.019 
Ethanol–toluene 
40 0.971 0.195 1.005 1.222 
40 1.091 1.059 – 1.173 
50 0.863 0.933 – 1.159 
60 0.654 0.701 0.272 0.815 
70 0.540 0.598 0.219 0.577 
Water–methanol 
80 0.593 0.528 0.340 0.511 
10 1.261 1.201 – 1.431 
20 1.113 0.983 0.505 1.189 
30 1.008 0.844 0.413 1.050 
40 0.806 0.800 0.403 0.957 
Water–acetone 
50 0.725 0.716 0.429 0.858 
In order to check the applicability of normal-phase thin-layer chromate-
graphy for the determination of the lipophilicity of the examined substances, the 
hydrophobic parameters 0ΜR  and C0 were correlated with computer-assisted cal-
culations of the values of log P11 and with experimentally determined ones.26 
Experimentally determined log P values are available for substances 1 (2.45), 3 
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(3.72), 5 (6.61) and 7 (–1.22). As it can be seen from Tables VI and VII, rela-
tively satisfactory linear relationships27 were obtained for all solvent systems em-
ployed in this study (in all instances r was statistically significant at the P < 0.05 
level). 
 
(A) 
 
(B) 
 
(C) 
Fig. 1. Dependence of the RM values on the 
volume fraction (y) of ethanol in: A) ethanol–
–ethyl methyl ketone, B) ethanol–carbon te-
trachloride and C) ethanol–toluene. The num-
bers denote the substances, see Table I. 
Comparison of these results with previous data obtained by reversed-phase 
TLC11 strongly recommends normal-phase thin-layer chromatography as a suit-
able method for the estimation of the lipophilicity of the examined substances. 
In addition, the hydrophobic parameters, 0ΜR , obtained throughout the pre-
sent study by normal-phase TLC using ethanol–ethyl methyl ketone, were corre-
lated with the 0ΜR  parameters obtained by reversed-phase TLC using water–me-
thanol as the mobile phase. Based on the relationship presented in Fig. 2, it can 
be seen that the examined substances are classified into groups forming two 
series. The metabolites of the examined ACE inhibitors, being more polar than 
the corresponding parent molecules, belong to the first series and the second se-
ries includes the more lipophilic ACE inhibitors, themselves. The exception is fo- 
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TABLE VI. Equations and correlation coefficients for 0ΜR  and C0 vs. the calculated log P 
values 
Solvent system Equation –r SD 
0ΜR  = 1.874 ± (0.355) – (1.212 ± (0.372)) log P 0.825 0.786 Ethanol–ethyl methyl 
ketone C0 = 0.775 ± (0.143) – (0.512 ± (0.150)) log P 0.836 0.317 
0ΜR  = 1.855 ± (0.288) – (0.944 ± (0.302)) log P 0.813 0.638 Ethanol–carbon 
tetrachloride C0 = 1.130 ± (0.154) – (0.424 ± (0.162)) log P 0.761 0.342 
0ΜR  = 1.488 ± (0.247) – (0.868 ± (0.259)) log P 0.832 0.547 Ethanol–toluene 
C0 = 1.093 ± (0.097) – (0.460 ± (0.102)) log P 0.897 0.215 
TABLE VII. Equations and correlation coefficients for 0ΜR  and C0 vs. the experimentally de-
termined log P values 
Solvent system Equation –r SD 
0ΜR  = 2.019 ± (0.650) – (0.387 ± (0.161)) log P 0.861 0.907 Ethanol–ethyl methyl 
ketone C0 = 0.556 ± (0.341) – (0.098 ± (0.085)) log P 0.632 0.477 
0ΜR  = 2.036 ± (0.647) – (0.304 ± (0.160)) log P 0.801 0.902 Ethanol–carbon 
tetrachloride C0 = 1.042 ± (0.303) – (0.126 ± (0.075)) log P 0.765 0.422 
0ΜR  = 1.527 ± (0.332) – (0.267 ± (0.082)) log P 0.917 0.462 Ethanol–toluene 
C0 = 1.126 ± (0.182) – (0.164 ± (0.045)) log P 0.931 0.254 
sinoprilat, which practically represents an outlier for the metabolites. However, 
this deviation is in accordance with the structural diversity of the investigated 
substances: in contrast to the other studied metabolites that contain two carbo-
xylic groups, fosinopirilat contains one carboxylic and one phosphinyl group. (As 
is known, a good correlation is only possible in closely related analogue series.1) 
Fig. 2. Correlation between the NP 
(ethanol–ethyl methyl ketone) and RP 
(water–methanol) lipophilicity chroma-
tographic data. The numbers denote the 
substances, see Table I. 
CONCLUSIONS 
The results obtained during the current study on the retention behaviour of 
several ACE inhibitors and their metabolites applying normal-phase TLC on 
silica gel plates, i.e., conspicuous differences between the RF values of these two 
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groups of substances, clearly demonstrate that this method is very suitable for 
their chromatographic separation. Based on the observed correlation of the chro-
matographically determined hydrophobicity parameters 0ΜR  and C0 and com-
puter-assisted calculated log P values, it can be concluded that normal-phase 
TLC represents a reliable method for an estimation of the lipophilicity of the 
examined substances. Comparison of the results obtained by normal-phase TLC 
with those obtained by conventional reversed-phase TLC revealed no significant 
differences with regard to the estimation of the lipophilicity. 
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И З В О Д  
НОРМАЛНО-ФАЗНА ТАНКОСЛОЈНА ХРОМАТОГРАФИЈА НЕКИХ ACE 
ИНХИБИТОРА И ЊИХОВИХ МЕТАБОЛИТА 
JAДРАНКА ОДОВИЋ1, MИРЈАНА АЛЕКСИЋ1, БИЉАНА СТОЈИМИРОВИЋ2, 
ДУШАНКА МИЛОЈКОВИЋ-ОПСЕНИЦА3 и ЖИВОСЛАВ ТЕШИЋ3 
1Farmaceutski fakultet, Univerzitet u Beogradu, p. pr. 146, 11001 Beograd, 2Medicinski fakultet, 
Univerzitet u Beogradu, p. pr. 840, 11000 Beograd i 3Hemijski fakultet, 
Univerzitet u Beogradu, p. pr.51, 11001 Beograd 
Хроматографско раздвајање и понашање пет АСЕ инхибитора (инхибитора ангио-тен-
зин-конвертујућег ензима) и њихова четири активна метаболита испитивано је методом 
нормално-фазне танкослојне хроматографије на силика-гелу применом неколико једно- и 
дво-компонентних неводених система растварача. Добијена је линеарна зависност између 
RM-вредности и концентрације етанола у мобилној фази. На основу одговарајућих регре-
сионих података, по аналогији са реверзно-фазном хроматографијом, израчунати су пара-
метри липофилности 0ΜR  и C0. Хроматографски добијени параметри хидрофобности коре-лисани су са израчунатим log P вредностима. Такође, 0ΜR –вредности добијене у овом раду корелисане су са 0ΜR –вредностима добијеним методом реверзно-фазне танкослојне хрома-тографије. 
(Примљено 16. октобра 2008) 
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